MedTrace Logo

The Benefit of Functional Movement Control for Patients With Knee Osteoarthritis

NCT03431298 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-08-28

No results posted yet for this study

Summary

The study purpose is to explore the effect of functional movement control for patients who have stage II or III degenerative knee joint disease and also physical inactive. Half of patients will receive aerobic exercise and functional movement control training in combination, while the other will simply receive aerobic exercise.

Conditions

Interventions

BEHAVIORAL

Aerobic exercise & movement control

The aerobic exercise content is no different between the experimental group and the active comparator group. The movement control is individual training which divided into fourths progressing sessions. * First, lumbo-pelvic and hip dynamic direction control. * Second, trunk muscle groups, hip muscle groups and thigh muscle groups extensibility control. * Third, trunk muscle groups and hip muscle groups through range control. * Fourth, functional movement control training

BEHAVIORAL

Aerobic exercise

The aerobic exercise will organized in groups. Each group has 6-8 persons. The exercise form is fixed at each time. The description of exercise form is as below: * 10 min Warm up * 40 min Aerobic exercise (which focus on lower extremity muscle strengthening and increasing muscle endurance) * 10 min Cool down

Sponsors & Collaborators

  • National Yang Ming Chiao Tung University

    lead OTHER

Principal Investigators

  • Wen-Yin Chen, PhD · National Yang-Ming University The Department of Physical Therapy and Assistive Technology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03431298 on ClinicalTrials.gov